Erceg, S.; Ninić, A.; Kotur-Stevuljević, J.; Ben Mariem, O.; Mitrović, M.; Munjas, J.; Sopić, M.; Misita, B.; Mamić, M.; Klisic, A.;
et al. Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes. Med. Sci. 2025, 13, 326.
https://doi.org/10.3390/medsci13040326
AMA Style
Erceg S, Ninić A, Kotur-Stevuljević J, Ben Mariem O, Mitrović M, Munjas J, Sopić M, Misita B, Mamić M, Klisic A,
et al. Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes. Medical Sciences. 2025; 13(4):326.
https://doi.org/10.3390/medsci13040326
Chicago/Turabian Style
Erceg, Sanja, Ana Ninić, Jelena Kotur-Stevuljević, Omar Ben Mariem, Miloš Mitrović, Jelena Munjas, Miron Sopić, Boško Misita, Milica Mamić, Aleksandra Klisic,
and et al. 2025. "Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes" Medical Sciences 13, no. 4: 326.
https://doi.org/10.3390/medsci13040326
APA Style
Erceg, S., Ninić, A., Kotur-Stevuljević, J., Ben Mariem, O., Mitrović, M., Munjas, J., Sopić, M., Misita, B., Mamić, M., Klisic, A., & Tomašević, R.
(2025). Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes. Medical Sciences, 13(4), 326.
https://doi.org/10.3390/medsci13040326
